According to statistics from the Particle Therapy Co‑Operative Group (PTCOG), by 2021, more than 260,000 patients worldwide had received proton or heavy‑ion therapy. The number of proton centers grew from 1 in 1990 to over 100 today, and is still rising rapidly. Proton therapy has become a major global trend in precision cancer radiotherapy.

Rectal cancer care is now defined by precision, individualization and function priority: 1.Precision evaluation: MRI and CT for accurate tumor mapping 2.MDT collaboration: colorectal surgery, radiotherapy, oncology, radiology 3.Technical innovation: robotic surgery, neoadjuvant therapy, Cai’s Stent, Parks procedure 4.Patient‑centered: tailored to age, function needs and economic status

Recently, a team led by Chief Physician Chen Yicheng from the Department of Urology at Sir Run Run Shaw Hospital of Zhejiang University, together with a multidisciplinary team (MDT) including Nuclear Medicine, Medical Oncology, and Radiology, successfully administered Lutetium-177 Tixivapitide Injection (radioligand therapy) to a 70-something patient with prostate cancer.

Why is childhood eczema so common in spring? Childhood eczema is a chronic inflammatory skin disease closely related to skin barrier function and immune status. Its onset is linked to genetics, immunity, environment and other factors. The climatic and environmental characteristics of spring act as a “catalyst” for eczema flareups, leading to high incidence.

Director Pang Wenjuan gave an example that in her recent consultation with an expatriate couple, in addition to explaining in detail the differences between Chinese and foreign IVF protocols, the hospital's Overseas Medical Department can also assist in providing fertility demand consulting and psychological assessment for fertility preservation (there are also overseas patients coming to China for treatment, such as a recent patient from Bangladesh who requested IVF at Jiahu

This article presents the diagnosis and treatment course of a 67-year-old female patient with ES-SCLC. Through two MDT discussions and based on the latest clinical research evidence, an individualized regimen of “first-line immunotherapy + chemotherapy + anti-angiogenesis therapy → local radiotherapy → combined maintenance therapy” was formulated. The patient finally achieved stable disease and symptom relief.providing practical reference for the diagnosis and treatment of ES